Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 06, 2022

SELL
$40.23 - $47.74 $146,477 - $173,821
-3,641 Reduced 8.02%
41,738 $1.82 Million
Q1 2021

May 03, 2021

BUY
$34.27 - $40.01 $188,622 - $220,215
5,504 Added 13.8%
45,379 $1.62 Million
Q4 2020

Feb 03, 2021

SELL
$34.07 - $39.94 $61,530 - $72,131
-1,806 Reduced 4.33%
39,875 $1.47 Million
Q1 2020

Apr 22, 2020

SELL
$32.47 - $48.83 $39,061 - $58,742
-1,203 Reduced 2.81%
41,681 $1.58 Million
Q4 2019

Jan 23, 2020

SELL
$42.0 - $48.25 $63,000 - $72,375
-1,500 Reduced 3.38%
42,884 $2.02 Million
Q1 2019

Apr 30, 2019

SELL
$38.57 - $42.69 $77,140 - $85,380
-2,000 Reduced 4.31%
44,384 $1.78 Million
Q3 2018

Nov 06, 2018

SELL
$39.75 - $42.69 $180,942 - $194,324
-4,552 Reduced 8.94%
46,384 $1.86 Million
Q2 2018

Jul 30, 2018

SELL
$39.61 - $42.76 $191,752 - $207,001
-4,841 Reduced 8.68%
50,936 $2.05 Million
Q1 2018

Apr 23, 2018

SELL
$36.18 - $40.15 $144,720 - $160,600
-4,000 Reduced 6.69%
55,777 $2.18 Million
Q4 2017

Feb 07, 2018

BUY
$35.34 - $41.9 $45,942 - $54,470
1,300 Added 2.22%
59,777 $2.12 Million
Q3 2017

Oct 25, 2017

BUY
$39.44 - $41.55 $2.31 Million - $2.43 Million
58,477
58,477 $2.37 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Meyer Handelman CO Portfolio

Follow Meyer Handelman CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.